Difference between revisions of "TG002644"
Jump to navigation
Jump to search
Line 4: | Line 4: | ||
|nrt=158.483 | |nrt=158.483 | ||
|ntransition=6 | |ntransition=6 | ||
− | |pepnrt=use (+1. | + | |pepnrt=use (+1.409) |
|peptide=PE000016 | |peptide=PE000016 | ||
|prt=74.610 | |prt=74.610 |
Revision as of 16:08, 14 May 2021
Peptide | R.CSDGWSFDATTLDDN[H5N4S2]GTMLFFK.G (PE000016) |
---|---|
Sequence | CSDGWSFDATTLDDNGTMLFFK |
Glycans(s) | H5N4S2 (N15) |
Mod(s) | 57.021 (C1) |
Molecular Weight | 4,749.85 |
Charge | 3+ |
Protein | HPX (P02790) |
Spectrum File | MS_35_Frac_plasma_run01_fr8_01 |
Method | Orbitrap Fusion-Lumos, DDA (EThcD pd HCD), nano LC-MS/MS |
Analytical Fraction | SAX-ERLICH Enrichment |
Sample | Human Serum |
Transitions
Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Prod. m/z | Prod. z | Label | %Int |
---|---|---|---|---|---|---|---|---|
76.626 | 74.610 | 158.483 | 1,578.292 | 3+ | 1,366.087 | 2+ | Y[pN] | 29.9 |
76.626 | 74.610 | 158.483 | 1,578.292 | 3+ | 1,893.272 | 2+ | Y[pH4N3] | 18.6 |
76.626 | 74.610 | 158.483 | 1,578.292 | 3+ | 1,812.246 | 2+ | Y[pH3N3] | 10.3 |
76.626 | 74.610 | 158.483 | 1,578.292 | 3+ | 1,957.794 | 2+ | Y[pH3N3S] | 7.6 |
76.626 | 74.610 | 158.483 | 1,578.292 | 3+ | 1,629.680 | 2+ | Y[pH2N2] | 6.2 |
76.626 | 74.610 | 158.483 | 1,578.292 | 3+ | 1,710.706 | 2+ | Y[pH3N2] | 5.1 |
Spectra
19837;EThcD;77.824;19826;1578.292;Byonic:q-value=3.07e-08/GPS:MinICScore=91.737
19839;HCD;77.832;19826;1578.292;
20059;EThcD;78.651;20049;1578.616;Byonic:q-value=1.43e-07/GPS:MinICScore=53.138
20061;HCD;78.658;20049;1578.616;